Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 36, 2022 - Issue 18
146
Views
1
CrossRef citations to date
0
Altmetric
Research Article

Anti-osteoclastogenic cycloartane saponins from Mussaenda pubescens

, , , , , , & show all
Pages 4591-4598 | Received 31 Jul 2021, Accepted 19 Nov 2021, Published online: 13 Dec 2021

References

  • An J, Hao D, Zhang Q, Chen B, Zhang R, Wang Y, Yang H. 2016. Natural products for treatment of bone erosive diseases: the effects and mechanisms on inhibiting osteoclastogenesis and bone resorption. Int Immunopharmacol. 36:118–131.
  • Baron R, Ferrari S, Russell RGG. 2011. Denosumab and bisphosphonates: different mechanisms of action and effects. Bone. 48(4):677–692.
  • Chi VV. 1999. The dictionary of Vietnamese medicinal plants. Hanoi (Vietnam): Hanoi Medicine.
  • Feng X, McDonald J. M. 2011. Disorders of bone remodeling. Annu. Rev. Pathol. 6:121–145.
  • Hien LTT, Thao LTP, Thuong LQ, Viet TQ, Trung DV. 2017. Chemical constituents of Mussaenda pubescens (Rubiaceae) [Vietnamese]. Vietnam J Chem. 55(3):355–359.
  • Huong LT, Trang DT, Dang NH. 2021. Screening for Vietnamese plant extracts with potential benefit for anti osteoclastogenesis. Vietnam J Sci Technol. 59(4):507–517.
  • Kennel KA, Drake MT 2009. Adverse effects of bisphosphonates: Implications for osteoporosis management. Mayo Clin. Proc. 84(7):632–638.
  • Kong X, Yang Y, Wu W, Wan H, Li X, Zhong M, Su X, Jia S, Lin N. 2015. Triterpenoid saponin W3 from Anemone flaccida suppresses osteoclast differentiation through inhibiting activation of MAPKs and NF-κB Pathways. Int J Biol Sci. 11(10):1204–1214.
  • Kostenuik PJ, Nguyen HQ, McCabe J, Warmington KS, Kurahara C, Sun N, Chen C, Li L, Cattley RC, Van G, et al. 2009. Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine/human) RANKL. J Bone Miner Res. 24(2):182–195.
  • Lazner F, Gowen M, Pavasovic D, Kola I. 1999. Osteopetrosis and osteoporosis: two sides of the same coin. Hum. Mol. Genet. 8(10):1839–1846.
  • Sethi G, Aggarwal BB. 2007. Mending the bones with natural products. Chem Biol. 14(7):738–740.
  • Sun YN, Li W, Lee SH, Jang HD, Ma JY, Kim YH. 2017. Antioxidant and anti-osteoporotic effects of anthraquinones and related constituents from the aqueous dissolved Aloe exudates. Nat Prod Res. 31(23):2810–2813.
  • Thu VK, Bach NX, Anh LT, Trang DT, Nhiem NX, Tai BH, Van Kiem P, Van Minh C, Park S, Seo Y, et al. 2019. Discovery of cycloartane-type triterpene saponins from Mussaenda glabra. Phytochem Lett. 33:39–45.
  • Tran PT, Dat NT, Dang NH, Van Cuong P, Lee S, Hwangbo C, Van Minh C, Lee JH. 2019. Ganomycin I from Ganoderma lucidum attenuates RANKL-mediated osteoclastogenesis by inhibiting MAPKs and NFATc1. Phytomedicine. 55:1–8. 10.1080/14786419.2021.1913589.
  • Wang SQ, Liu B, Liu S, Xie SZ, Pan LH, Zha XQ, Li QM, Luo JP. 2020. Structural features of an acidic polysaccharide with the potential of promoting osteoblast differentiation from Lycium ruthenicum Murr. Nat Prod Res. 34(16):2249–2254.
  • Wei X, Huang XT, Zhang LY, Hu XY, Zhang W, Zhou YQ, Yu HF, Ding CF, Zhang LC, Liu X, et al. 2021. New oxindole alkaloids with selective osteoclast inhibitory activity from Gelsemium elegans. Nat Prod Res. 1–7.
  • Weimin Z, Junping X, Guowei Q, Rensheng X. 1995. Saponins from Mussaenda pubescens. Phytochemistry. 39(1):191–193.
  • Weimin Z, Rensheng X, Guowei Q, Wu H, Jiang S, Yan G. 1996. A new phenolic glycoside from Mussaenda pubescens. Nat Prod Sci. 2(1):14–18.
  • Zhao W, Wolfender J-L, Hostettmann K, Cheng K, Xu R, Qin G. 1997. Triterpenes and triterpenoid saponins from Mussaenda pubescens. Phytochemistry. 45(5):1073–1078.
  • Zhao W, Xu J, Qin G, Xu R, Wu H, Weng G. 1994. New triterpenoid saponins from Mussaenda pubescens. J Nat Prod. 57(12):1613–1618.
  • Zhao W, Xu R, Qin G, Vaisar T, Lee MS. 1996a. Saponins from Mussaenda pubescens. Phytochemistry. 42(4):1131–1134.
  • Zhao W-M, Yang G-J, Xu R-S, Qin G-W. 1996b. New saponins from Mussaenda pubescens. Nat Prod Lett. 8(2):119–126.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.